Crossmark

N-acetylcysteine reduces serum creatinine, blood urea nitrogen, symmetric dimethylarginine and urine protein to creatinine ratio in cats with chronic kidney disease: a double-blind, placebo-controlled clinical trial

Crossref DOI link: https://doi.org/10.1186/s12917-026-05328-8

Published Online: 2026-02-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ali̇hossei̇ni̇, Hadi

Çolakoğlu, Ekrem Çagatay

Haydardedeoğlu, Ali Evren

Özen, Doğukan
License Information

Text and Data Mining valid from 2026-02-03

Version of Record valid from 2026-03-03
More Information

Article History

Received: 14 August 2025

Accepted: 22 January 2026

First Online: 3 February 2026

Declarations

:

: Informed consent was obtained from all owners included in the study. The present study was carried out in accordance with the principles of the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes and the requirements of European Union Directive 2010/63 on the protection of animals used for experimental and other scientific purposes. The authors confirm that the ethical policies of the journal, as noted on the journal’s author guidelines page, have been adhered to and the appropriate ethical review committee approval has been received. The authors confirm that they have adhered to either US or European standards for the protection of animals used for scientific purposes.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below